Dietmar Dammerer: How Should We Manage Traumatic Brain Injury When on Anticoagulants?
Dietmar Dammerer, Head of the Department of Orthopedics and Traumatology at the University Hospital Krems, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Archives of Orthopaedic and Trauma Surgery, adding:
”NEW PUBLICATION.
How should we manage patients with mild traumatic brain injury who are taking anticoagulants?
Despite the growing number of patients on antithrombotic therapy presenting to emergency departments after head trauma, clinical practice remains far from uniform.
I’m excited to share our newly published nationwide survey examining how Austrian trauma and neurosurgical departments manage patients with mild traumatic brain injury (mTBI) receiving antiplatelet agents, vitamin K antagonists, or direct oral anticoagulants.
Key findings:
- Nearly all participating departments routinely perform cranial CT scans in anticoagulated patients after mild head injury.
- Significant regional differences exist regarding hospital admission practices, particularly for patients receiving DOACs and those with hemophilia.
- Management strategies vary considerably across Austria, highlighting the absence of up-to-date national guidance.
As healthcare systems face increasing patient volumes and resource constraints, standardized, evidence-based protocols are becoming more important than ever.
Our findings underline a clear opportunity: developing contemporary national guidelines that support both patient safety and efficient resource utilization.
A sincere thank you to all participating departments and colleagues who contributed to this nationwide effort.
The full publication is now available, and I look forward to discussing its implications for trauma care, emergency medicine, neurosurgery, and healthcare policy.”
Title: Regional differences in the management of patients with mild traumatic brain injury and antithrombotic therapy—an Austrian survey
Authors: Barbara Sebek, Dietmar Dammerer, David Putzer, Lukas Moser
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 26, 2026, 01:48Rob Maloney: Why Global Diagnosis is the Missing Piece in Bleeding Disorder Care
-
Jul 26, 2026, 01:35Moustafa Abdou: Ehlers-Danlos Syndrome – Why Collagen Matters for Hemostasis
-
Jul 26, 2026, 01:25Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
-
Jul 26, 2026, 01:06Christine Bork: Why Misinformation Around a Single Vitamin Postpartum is Putting Babies at Risk
-
Jul 26, 2026, 00:44A Significant Step Forward For People With Bleeding Disorders In The Dominican Republic – WFH
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026